BioMarin Pharmaceutical, Inc. (BMRN)
63.83
+0.91
(+1.45%)
USD |
NASDAQ |
Feb 24, 11:30
BioMarin Pharmaceutical Price : 63.83 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.34 |
| Gilead Sciences, Inc. | 148.67 |
| Merck & Co., Inc. | 124.15 |
| AbbVie, Inc. | 228.65 |
| Bristol Myers Squibb Co. | 61.64 |
Price Related Metrics
| PE Ratio | 23.92 |
| PS Ratio | 4.046 |
| PEG Ratio | 0.3939 |
| Price to Book Value | 2.025 |
| Price to Free Cash Flow | 15.11 |
| Earnings Yield | 4.18% |
| Market Cap | 12.26B |
| PEGY Ratio | 0.3939 |
| Operating PE Ratio | 14.59 |
| Normalized PE Ratio | 17.89 |